SAM
WST icon

Storebrand Asset Management’s West Pharmaceutical WST Stock Holding History

Storebrand Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.6M Hold
7,239
– – 0.01% 571
2026
Q1 		$1.81M Sell
7,239
-402
-5% -$100K 0.01% 583
2025
Q4 		$2.1M Sell
7,641
-206
-3% -$56.3K 0.01% 575
2025
Q3 		$2.06M Sell
7,847
-384
-5% -$93.3K 0.01% 594
2025
Q2 		$1.8M Buy
8,231
+57
+0.7% +$12.2K 0.01% 605
2025
Q1 		$1.83M Sell
8,174
-5,897
-42% -$1.63M 0.01% 602
2024
Q4 		$4.61M Buy
14,071
+1,132
+9% +$356K 0.01% 508
2024
Q3 		$3.88M Sell
12,939
-267
-2% -$81.8K 0.01% 539
2024
Q2 		$4.35M Sell
13,206
-1,062
-7% -$375K 0.01% 514
2024
Q1 		$5.65M Buy
14,268
+710
+5% +$263K 0.02% 485
2023
Q4 		$4.77M Buy
13,558
+441
+3% +$156K 0.02% 512
2023
Q3 		$4.92M Sell
13,117
-1,367
-9% -$529K 0.02% 480
2023
Q2 		$5.54M Buy
14,484
+856
+6% +$306K 0.03% 475
2023
Q1 		$4.72M Sell
13,628
-1,042
-7% -$304K 0.02% 500
2022
Q4 		$3.45M Sell
14,670
-2,124
-13% -$503K 0.02% 524
2022
Q3 		$4.13M Sell
16,794
-8,764
-34% -$2.67M 0.02% 488
2022
Q2 		$7.73M Sell
25,558
-1,433
-5% -$466K 0.04% 396
2022
Q1 		$11.1M Sell
26,991
-1,526
-5% -$597K 0.05% 354
2021
Q4 		$13.4M Buy
28,517
+4,483
+19% +$1.93M 0.06% 329
2021
Q3 		$10.2M Buy
24,034
+2,133
+10% +$899K 0.05% 370
2021
Q2 		$7.86M Sell
21,901
-334
-2% -$110K 0.04% 423
2021
Q1 		$6.27M Sell
22,235
-253
-1% -$72.4K 0.03% 459
2020
Q4 		$6.37M Sell
22,488
-475
-2% -$133K 0.04% 435
2020
Q3 		$6.31M Buy
22,963
+3,479
+18% +$921K 0.05% 376
2020
Q2 		$4.43M Buy
19,484
+9,907
+103% +$1.95M 0.04% 415
2020
Q1 		$1.46M Buy
+9,577
New +$1.47M 0.02% 578

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Storebrand Asset Management's WST Position: Q2 2026 in Review

Storebrand Asset Management held its West Pharmaceutical (WST) position steady in Q2 2026 at 7,239 shares worth $2.6M. The position accounts for 0.01% of the portfolio, ranked #571.

Storebrand Asset Management first reported a position in WST in Q1 2020 and has held it in 26 quarters since. The position peaked at $13.4M in Q4 2021. 785 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Storebrand Asset Management held 7,239 shares of West Pharmaceutical worth $2.6M as of Q2 2026.
  • Storebrand Asset Management left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up 0.01% of Storebrand Asset Management's portfolio in Q2 2026, its #571 holding.
  • Storebrand Asset Management first reported a position in West Pharmaceutical in Q1 2020 and has held it in 26 quarters since.
  • Storebrand Asset Management's West Pharmaceutical position peaked at $13.4M in Q4 2021.
  • 785 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Storebrand Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.